Baillie Gifford & Co

Baillie Gifford & Co’s Unity Biotechnology UBX Stock Holding History

Baillie Gifford & Co’s Portfolio UBX Stock Details UBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-58,911	Closed	-$233K	–	494
2022 Q3	$233K	Hold	58,911	–	–	﹤0.01%	291
2022 Q2	$332K	Hold	58,911	–	–	﹤0.01%	293
2022 Q1	$660K	Hold	58,911	–	–	﹤0.01%	282
2021 Q4	$860K	Hold	58,911	–	–	﹤0.01%	281
2021 Q3	$1.77M	Sell	58,911 -171,500	-74%	-$6.05M	﹤0.01%	266
2021 Q2	$10.7M	Sell	230,411 -149,890	-39%	-$7.22M	0.01%	244
2021 Q1	$22.8M	Hold	380,301	–	–	0.01%	220
2020 Q4	$19.9M	Hold	380,301	–	–	0.01%	202
2020 Q3	$13.2M	Hold	380,301	–	–	0.01%	198
2020 Q2	$33M	Hold	380,301	–	–	0.03%	148
2020 Q1	$22.1M	Hold	380,301	–	–	0.02%	144
2019 Q4	$27.4M	Hold	380,301	–	–	0.03%	147
2019 Q3	$23.2M	Hold	380,301	–	–	0.03%	148
2019 Q2	$36.1M	Hold	380,301	–	–	0.04%	140
2019 Q1	$30.8M	Hold	380,301	–	–	0.03%	142
2018 Q4	$61.8M	Hold	380,301	–	–	0.08%	108
2018 Q3	$62M	Hold	380,301	–	–	0.07%	113
2018 Q2	$57.3M	Buy	+380,301	New	+$55.6M	0.06%	107

Other funds holding UBX

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alyeska Investment Group

Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return

Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return